GV-ROX

This brand name is authorized in Nigeria.

Active ingredients

The drug GV-ROX contains one active pharmaceutical ingredient (API):

1	Cefuroxime UNII Z49QDT0J8Z - CEFUROXIME AXETIL
	Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
	Read more about Cefuroxime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7358	Powder for suspension	GV-ROX POWDER FOR ORAL SUSPENSION PWD_F_SOL 125 mg/5 mL 1X100ML	85 RNW-PP-275415 GV-ROX POWDER FOR ORAL SUSPENSION CEFUROXIME AXETIL 125MG/5ML CEFUROXIME AXETIL 125MG/5ML A4-7358 Drugs Imported Products 1100ML Prescription Only Medicine (POM) 8/12/2022 GREENVILLE PHARMA NIGERIA LIMITED, 12 OPEYEMI CLOSE OLUWONLA, BASHORUN IBADAN, OYO STATE 8037121693 greenvillepharma2@gmail.com VAPICARE PHARMA. PVT. LIMITED, PLOT NO 225/3. G.I.D.C, NEAR MORARJI CIRCLE, VAPI - 396 195, DIST, VALSAD, GUJARAT, INDIA, India	25/05/2023
A4-7595	Tablet	GV-ROX TABLET TAB 500 mg 2 X 5	84 RNW-PP-275414 GV-ROX TABLET CEFUROXIME AXETIL 500MG CEFUROXIME AXETIL 500MG, MAIZE STARCH, MAGNESIUM STEARATE A4-7595 Drugs Imported Products 25 Prescription Only Medicine (POM) 8/12/2022 GREENVILLE PHARMA NIGERIA LIMITED, 12 OPEYEMI CLOSE OLUWONLA, BASHORUN IBADAN, OYO STATE 8037121693 greenvillepharma2@gmail.com VAPICARE PHARMA. PVT. LIMITED, PLOT NO 225/3. G.I.D.C, NEAR MORARJI CIRCLE, VAPI - 396 195, DIST, VALSAD, GUJARAT, INDIA, India	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DC02	Cefuroxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7358, A4-7595